Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T15:52:05.647Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:52:05.647Z.

Quote observation: 2026-10-06T15:50:06.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 12.545
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.95

FMP input reference: 880033b02c1352d2eede0b9825b135807cf5616a7da0006e335be03a15b23327

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

MASS PE Ratio Metrics

PE RATIO

N/A

PE RATIO AVG TTM

N/A

PE RATIO AVG 3Y

N/A

PE RATIO AVG 5Y

N/A

PE RATIO AVG 10Y

N/A

PE RATIO AVG 15Y

N/A

PE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

MASS Competitors' PE Ratio

MASS

908 Devices Inc.

Current

Market Cap

$514.69M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALLO

Allogene Therapeutics, Inc.

vs MASS

Market Cap

$510.83M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALT

Altimmune, Inc.

vs MASS

Market Cap

$521.87M

PE Ratio

N/A

TTM Avg

0.20

3Y Avg

0.20

5Y Avg

0.20

MNPR

Monopar Therapeutics Inc.

vs MASS

Market Cap

$521.70M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CBIO

Crescent Biopharma, Inc.

vs MASS

Market Cap

$523.02M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OCS

Oculis Holding AG

vs MASS

Market Cap

$497.95M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMMX

Immix Biopharma, Inc.

vs MASS

Market Cap

$537.49M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PHAT

Phathom Pharmaceuticals, Inc.

vs MASS

Market Cap

$539.61M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EOLS

Evolus, Inc.

vs MASS

Market Cap

$490.95M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCTH

Delcath Systems, Inc.

vs MASS

Market Cap

$540.78M

PE Ratio

1205.00

TTM Avg

806.49

3Y Avg

715.80

5Y Avg

715.80

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
908 Devices Inc. (MASS)	$514.69M	N/A	N/A	N/A	N/A
Allogene Therapeutics, Inc. (ALLO)vs ›	$510.83M	N/A	N/A	N/A	N/A
Altimmune, Inc. (ALT)vs ›	$521.87M	N/A	0.20	0.20	0.20
Monopar Therapeutics Inc. (MNPR)vs ›	$521.70M	N/A	N/A	N/A	N/A
Crescent Biopharma, Inc. (CBIO)vs ›	$523.02M	N/A	N/A	N/A	N/A
Oculis Holding AG (OCS)vs ›	$497.95M	N/A	N/A	N/A	N/A
Immix Biopharma, Inc. (IMMX)vs ›	$537.49M	N/A	N/A	N/A	N/A
Phathom Pharmaceuticals, Inc. (PHAT)vs ›	$539.61M	N/A	N/A	N/A	N/A
Evolus, Inc. (EOLS)vs ›	$490.95M	N/A	N/A	N/A	N/A
Delcath Systems, Inc. (DCTH)vs ›	$540.78M	1205.00	806.49	715.80	715.80

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$12.54

÷

Forward EPS (Est.)

$-0.86

=

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

MASS PE Ratio History

DATE	PE RATIO
2026-05-06	14.65
2026-05-05	12.89
2026-05-04	11.91
2026-05-01	12.38
2026-04-30	12.42
2026-04-29	11.82
2026-04-28	12.25
2026-04-27	12.25
2026-04-24	12.25
2026-04-23	12.29
2026-04-22	12.96
2026-04-21	13.20
2026-04-20	13.27
2026-04-17	13.02
2026-04-16	13.49
2026-04-15	13.40
2026-04-14	13.31
2026-04-13	13.09
2026-04-10	12.98
2026-04-09	12.65
2026-04-08	12.78
2026-04-07	12.29
2026-04-06	12.45
2026-04-02	12.02
2026-04-01	11.29
2026-03-31	11.13
2026-03-30	10.45
2026-03-27	10.51
2026-03-26	11.16
2026-03-25	11.49
2026-03-24	11.40
2026-03-23	11.11
2026-03-20	11.11
2026-03-19	11.07
2026-03-18	10.89
2026-03-17	11.31
2026-03-16	11.07
2026-03-13	11.04
2026-03-12	10.93
2026-03-11	11.38
2026-03-10	11.38

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

MASS PE Ratio Chart

MASS PE Ratio Metrics

MASS Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

MASS PE Ratio History

Related Metrics